KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 257 filers reported holding KARUNA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.01 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $191,285,261 | -6.9% | 1,131,263 | +19.3% | 0.78% | -7.8% |
| Q2 2023 | $205,564,042 | -24.6% | 947,955 | -36.8% | 0.84% | -34.2% |
| Q1 2023 | $272,655,081 | +17.2% | 1,501,074 | +26.8% | 1.28% | +10.0% |
| Q4 2022 | $232,604,124 | +2.0% | 1,183,736 | +16.7% | 1.16% | +10.5% |
| Q3 2022 | $228,105,000 | +61.1% | 1,014,116 | -9.4% | 1.05% | +62.5% |
| Q2 2022 | $141,610,000 | +14.6% | 1,119,360 | +14.9% | 0.65% | +29.9% |
| Q1 2022 | $123,537,000 | +9.2% | 974,345 | +12.8% | 0.50% | +53.1% |
| Q4 2021 | $113,140,000 | +6.5% | 863,664 | -0.6% | 0.33% | +12.0% |
| Q3 2021 | $106,268,000 | +13.3% | 868,696 | +5.6% | 0.29% | +2.5% |
| Q2 2021 | $93,753,000 | +29.7% | 822,465 | +36.8% | 0.28% | +32.1% |
| Q1 2021 | $72,276,000 | +110.4% | 601,144 | +77.7% | 0.22% | +128.7% |
| Q4 2020 | $34,358,000 | -33.1% | 338,200 | -49.1% | 0.09% | -49.2% |
| Q3 2020 | $51,332,000 | – | 663,890 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pivotal bioVenture Partners Investment Advisor LLC | 782,008 | $142,043,933 | 58.49% |
| Nan Fung Group Holdings Ltd | 225,688 | $40,993,968 | 27.90% |
| Sofinnova Investments, Inc. | 1,773,124 | $322,070,243 | 20.60% |
| Artia Global Partners LP | 88,831 | $16,135,263 | 5.96% |
| DAFNA Capital Management LLC | 78,573 | $14,272,000 | 4.28% |
| First Light Asset Management, LLC | 243,675 | $44,261,127 | 3.98% |
| CATALYST PRIVATE WEALTH, LLC | 21,837 | $3,966,473 | 2.74% |
| Sands Capital Ventures, LLC | 58,895 | $10,697,688 | 2.64% |
| ARCH Venture Management, LLC | 30,000 | $5,449,200 | 2.63% |
| Logos Global Management LP | 100,000 | $18,164,000 | 2.60% |